Related references
Note: Only part of the references are listed.Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR
Jasmina Cehajic-Kapetanovic et al.
NATURE MEDICINE (2020)
Findings from a Genotyping Study of over 1000 People with Inherited Retinal Disorders in Ireland
Laura Whelan et al.
GENES (2020)
Safety and Vision Outcomes of Subretinal Gene Therapy Targeting Cone Photoreceptors in Achromatopsia A Nonrandomized Controlled Trial
M. Dominik Fischer et al.
JAMA OPHTHALMOLOGY (2020)
Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy
Paul F. Kenna et al.
BMJ OPEN OPHTHALMOLOGY (2020)
The Impact of Inherited Retinal Diseases in the Republic of Ireland (ROI) and the United Kingdom (UK) from a Cost-of-Illness Perspective
Orla Galvin et al.
CLINICAL OPHTHALMOLOGY (2020)
An ontological foundation for ocular phenotypes and rare eye diseases
Panagiotis I. Sergouniotis et al.
ORPHANET JOURNAL OF RARE DISEASES (2019)
Progress in the development of novel therapies for choroideremia
Jasmina Cehajic Kapetanovic et al.
EXPERT REVIEW OF OPHTHALMOLOGY (2019)
Retinal AAV8-RS1 Gene Therapy for X-Linked Retinoschisis: Initial Findings from a Phase I/IIa Trial by Intravitreal Delivery
Catherine Cukras et al.
MOLECULAR THERAPY (2018)
Toward an elucidation of the molecular genetics of inherited retinal degenerations
G. Jane Farrar et al.
HUMAN MOLECULAR GENETICS (2017)
Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial
Stephen Russell et al.
LANCET (2017)
Target 5000: Target Capture Sequencing for Inherited Retinal Degenerations
Adrian Dockery et al.
GENES (2017)
Comprehensive Rare Variant Analysis via Whole-Genome Sequencing to Determine the Molecular Pathology of Inherited Retinal Disease
Keren J. Carss et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2017)
Identifying variation in models of care for the genomic-based diagnosis of inherited retinal dystrophies in the United Kingdom
M. Eden et al.
EYE (2016)
Panel-Based Population Next-Generation Sequencing for Inherited Retinal Degenerations
Matthew Carrigan et al.
SCIENTIFIC REPORTS (2016)
Prevalence of age-related macular degeneration in the Republic of Ireland
Kwadwo Owusu Akuffo et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2015)
Variation in healthcare services for specialist genetic testing and implications for planning genetic services: the example of inherited retinal dystrophy in the English NHS
Mark Harrison et al.
JOURNAL OF COMMUNITY GENETICS (2015)
A comparison of the causes of blindness certifications in England and Wales in working age adults (16-64 years), 1999-2000 with 2009-2010
Gerald Liew et al.
BMJ OPEN (2014)
Understanding the expectations of patients with inherited retinal dystrophies
Ryan Combs et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2013)
Global Prevalence and Major Risk Factors of Diabetic Retinopathy
Joanne W. Y. Yau et al.
DIABETES CARE (2012)
Advantages and disadvantages of molecular testing in ophthalmology
Joanne E. Sutherland et al.
EXPERT REVIEW OF OPHTHALMOLOGY (2011)
Comprehensive screening of the USH2A gene in Usher syndrome type II and non-syndromic recessive retinitis pigmentosa
BJ Seyedahmadia et al.
EXPERIMENTAL EYE RESEARCH (2004)
Share Paper
